Identification of causal genetic drivers of human disease through systems-level analysis of regulatory networks.

Identification of driver mutations in human diseases is often limited by cohort size and availability of appropriate statistical models. We propose a framework for the systematic discovery of genetic alterations that are causal determinants of disease, by prioritizing genes upstream of functional disease drivers, within regulatory networks inferred de novo from experimental data. We tested this framework by identifying the genetic determinants of the mesenchymal subtype of glioblastoma. Our analysis uncovered KLHL9 deletions as upstream activators of two previously established master regulators of the subtype, C/EBPβ and C/EBPδ. Rescue of KLHL9 expression induced proteasomal degradation of C/EBP proteins, abrogated the mesenchymal signature, and reduced tumor viability in vitro and in vivo. Deletions of KLHL9 were confirmed in > 50% of mesenchymal cases in an independent cohort, thus representing the most frequent genetic determinant of the subtype. The method generalized to study other human diseases, including breast cancer and Alzheimer's disease.
AuthorsJames C Chen, Mariano J Alvarez, Flaminia Talos, Harshil Dhruv, Gabrielle E Rieckhof, Archana Iyer, Kristin L Diefes, Kenneth Aldape, Michael Berens, Michael M Shen, Andrea Califano
JournalCell (Cell) Vol. 159 Issue 2 Pg. 402-14 (Oct 9 2014) ISSN: 1097-4172 [Electronic] United States
PMID25303533 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Elsevier Inc. All rights reserved.
Chemical References
  • CEBPD protein, human
  • KLHL9 protein, human
  • Proteins
  • CCAAT-Enhancer-Binding Protein-delta
  • Proteasome Endopeptidase Complex
  • Algorithms
  • Alzheimer Disease (genetics)
  • Animals
  • Breast Neoplasms (genetics)
  • CCAAT-Enhancer-Binding Protein-delta (metabolism)
  • DNA Copy Number Variations
  • Gene Regulatory Networks
  • Glioblastoma (genetics, pathology)
  • Heterografts
  • Humans
  • Mice
  • Mutation
  • Neoplasm Transplantation
  • Proteasome Endopeptidase Complex (metabolism)
  • Proteins (metabolism)
  • Quantitative Trait Loci
  • Ubiquitination

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: